Loading insider details...
Beta
Latest Form 4 (Sep 4, 2026): Grant/Award of 17,000 PLX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 17,000 | n/a |
| Jul 17, 2026 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 25,000 | n/a |
| Sep 4, 2025 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 7,500 | n/a |
| Jun 25, 2025 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 15,000 | n/a |
| Jun 27, 2024 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 15,000 | n/a |
| May 16, 2024 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/Award | 7,693 | n/a |
| Oct 3, 2023 | Protalix BioTherapeutics, Inc. (PLX) | Grant/Award | 61,676 | n/a |
| Jun 26, 2023 | Gain Therapeutics, Inc. (GANX) | Grant/Award | 10,500 | n/a |
| May 26, 2023 | SOLENO THERAPEUTICS INC (SLNO) | Grant/Award | 2,666 | n/a |
| May 19, 2023 | COLLEGIUM PHARMACEUTICAL, INC (COLL) | Grant/Award | 9,792 | n/a |